What is the difference between Semaglutide and Survodutide?

Semaglutide (Semaglutide (Ozempic / Wegovy)) is graded A+ and is FDA-approved for weight management and type 2 diabetes. Survodutide (Survodutide (BI 456906)) is graded A and is Not FDA-approved — Phase 3 trials for obesity and MASH. They are commonly compared because they share the categories: weight-loss, metabolic.

Which has stronger clinical evidence — Semaglutide or Survodutide?

On our internal evidence scale, Semaglutide is A+ and Survodutide is A. A+ indicates large RCTs plus FDA approval; C indicates primarily preclinical or anecdotal evidence.

What is the typical dose of Semaglutide vs Survodutide?

Semaglutide: 0.25–2.4 mg weekly (subcutaneous injection). Survodutide: Trial range: 0.6–6 mg weekly (subcutaneous). Always work with a licensed clinician — peptide dosing should be individualized.

Semaglutide vs Survodutide

Both Semaglutide and Survodutide are used for weight-loss and metabolic. Here's how their evidence, dosing, and regulatory status actually compare.

Semaglutide

Evidence A+

Semaglutide (Ozempic / Wegovy)

A GLP-1 receptor agonist and the gold standard for evidence-based weight loss peptide therapy. Demonstrated 14.9–16.9% mean body weight reduction in the landmark STEP trials.

View full Semaglutide profile →

Survodutide

Evidence A

Survodutide (BI 456906)

A dual GLP-1 / glucagon receptor agonist with strong Phase 2 weight-loss and MASH data. Resolution of MASH in 83% of participants at the highest dose at week 48.

View full Survodutide profile →

Side-by-Side

Attribute	Semaglutide	Survodutide
Evidence Grade	A+	A
FDA Status	FDA-approved for weight management and type 2 diabetes	Not FDA-approved — Phase 3 trials for obesity and MASH
Typical Dose	0.25–2.4 mg weekly (subcutaneous injection)	Trial range: 0.6–6 mg weekly (subcutaneous)
Clinics Indexed	2,285	6
Categories	weight-loss, metabolic	weight-loss, metabolic

Key reported benefits — Semaglutide

✓Significant weight loss
✓Appetite suppression
✓Blood sugar control
✓Cardiovascular benefit

Key reported benefits — Survodutide

✓Weight loss
✓MASH resolution
✓Glucose control

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons